ADx NeuroSciences
@ADxNeuro
Followers
78
Following
18
Statuses
89
State-of-the-art biomarker assays for neurodegenerative diseases. LinkedIn: https://t.co/bhZno00vPD
Ghent, Belgium
Joined January 2022
Today, we’re shining a light on #Lewybodydementia💙 Our focus is on fluid biomarker discovery to support improved diagnosis and provide valuable insights in future LBD research 🧠🔬. Together, we can make a positive impact! #LBDawareness #Worldlewybodydementiaday
0
0
0
🌍 ADx is proud to join Synapsing, a Horizon-Europe-funded (€7M) project uniting 13 institutions across 9 countries, led by the Institut de Recerca Sant Pau. Thanks to Dr. Olivia Belbin, Dr. Maria J Portella, and all partners. Check out the press release below to learn more!
L'IR #SantPau liderarà Synapsing, un innovador projecte del programa Horizon-Europe per avançar en el diagnòstic i tractament de trastorns psiquiàtrics i malalties neurodegeneratives🧠 🏥Implicarà tretze institucions líders en investigació clínica, neuroimatge i ciències socials de nou països europeus, tindrà com a objectiu revolucionar el diagnòstic i la gestió de malalties psiquiàtriques i neurodegeneratives mitjançant biomarcadors sanguinis, dades socioeconòmiques i eines innovadores. 🚀La coordinació del projecte recaurà en la Dra. Olivia Belbin, cap del grup de Neurodegeneració Molecular de l’IR Sant Pau, que aportarà la seva experiència en investigació translacional i la Dra. Maria J Portella, cap del grup de recerca en Salut Mental, també tindrà un paper clau, aportant el seu coneixement especialitzat en salut mental. 🩸Synapsing generarà la primera col·lecció trans-europea de dades clíniques, de neuroimatge i sociodemogràfiques de més de 3000 pacients, en la qual per primera vegada s’analitzaran conjuntament tant els trastorns psiquiàtrics com les malalties neurodegeneratives. 🧬També s’estudiaran les connexions neuronals per entendre millor la base molecular i cel·lular de la disfunció neuronal que condueix a aquestes malalties, amb el possible desenvolupament de nous tractaments, i d’aquesta manera avançar tant en el diagnòstic com en el possible desenvolupament de tractaments. 🗣️“L’IR Sant Pau coordina per primera vegada un projecte europeu d’aquesta magnitud, marcant un esdeveniment històric en la nostra trajectòria i consolidant el nostre posicionament com a centre de referència en investigació clínica i translacional”, destaca la Dra. Belbin. #JuntsFemRecerca
@uni_ulm @goteborgsuni @Privanova_
0
0
1
We’re hiring a Junior Scientist for lab-scale production, validation, and QC of biomarker tests. ✅ Manage projects efficiently ✅ Bachelor’s/Master’s in lab techniques or related fields ✅ Immunoassay experience is a plus ✅ Fluent English & MS Office
0
0
1
✨As the year ends, we celebrate milestones and look to new opportunities. Our focus on high-quality biomarkers and immunoassays remains strong. In 2025, we’re excited to launch innovations to empower our partners.👩🔬🤝 Warm wishes for joyful holidays and a prosperous New Year!🎄
0
0
1
Heading to #CTAD24! 🧠 Eugeen will share insights on synaptic biomarkers in neurological diseases and their impact on research and treatment. 💡 Join us, our collaborators, and Fujirebio Group for key topics in #AlzheimersDisease #diagnostics #fluidbiomarkers. See you there! 👋
0
0
1
🌎 On #WorldAlzheimersDay, we join many in raising awareness. ADx is exploring fluid biomarkers and expanding our Tau and Synaptic panels to support research.🎥 Check out our video summarizing advancements over the years. Together, we can make a difference!💜#AlzheimersAwareness
0
0
0
Heads up, Philly! Jeroen's bringing not one, but 2 posters to #AAIC2024! 🚀 Swing by & learn more about: 🩸 New prototype plasma assays for pTau205 & brain-derived Tau on Lumipulse G1200 ⚙️An optimized version of a HomeBrew Simoa plasma assay for pTau181 #biomarkers #ADxInside
0
0
0
🤝Meet us at the CSF Society Conference in Barcelona! Learn more about the clinical performance of different synaptic biomarkers in neurodegenerative diseases and chronic conditions 🧠 #ADxInside #biomarkers #CSFSociety
0
0
0
Happy to have contributed to this new publication in @AlzheimersRes shedding light on NFL and GFAP as potential biomarkers for cerebrovascular amyloid angiopathy (CAA) 📰 #diagnostics #biomarkers #CAA #GFAP #NFL
0
0
0
Today on #WorldParkinsonsDay, we want to raise awareness for #ParkinsonsDisease 💙 We are determined to continue developing novel fluid biomarker assays for early diagnosis and providing valuable information in clinical trials 🧠👨🔬 #ParkinsonsAwareness
0
0
1
ABOARD joins forces with over 30 partners including ADx NeuroSciences ABOARD's mission is to kick start tailor-made treatment (personalized medicine) for #Alzheimers , by preparing for effective, patient-directed diagnosis, prediction and prevention. #BrainAwarenessWeek2024
De campagne ‘Uurtje voor Alzheimer’ gaat goed - het #ABOARDcohort bestaat nu uit ruim 9000 deelnemers! 🥳 Hoe meer mensen er meedoen, hoe sneller wij de ziekte in de toekomst kunnen opsporen. Dus de onderzoekers hebben flink campagne gevoerd! Lees meer:
0
0
0
📢Join the Fluid biomarkers and imaging session 2 at #ADPD2024 where Steffi De Meyer from #LAMON_KUL will talk about associations of plasma synaptic biomarkers VAMP2, SNAP25 and GFAP, pTau181 & NfL with synaptic imaging in non-demented elderly💉🧓☢ #ADxInside @KU_Leuven
2
1
1
Another insightful day at #ADPD2024! Grab a☕️and visit our posters on: 🔬the performance of our in-house pS129 synuclein prototype assay 🧠the distinct core and synaptic CSF biomarker profiles & cognitive trajectories investigated in #alzheimers patients with a history of TBI
3
1
2
Meet us at #ADPD2024 for exciting data on our novel prototypes for GFAP & pS129 alpha-synuclein as well as the evaluation of associations of ADx' synaptic biomarkers with synaptic/MRI imaging & cognitive trajectories in patients with #Alzheimer and #TBI .
5
1
3
🚨 Paper alert @JNeurochem Results from a new collaboration showing that a complete panel of Aβ species in CSF can be used to differentiated CAA from controls and AD-like subjects with high accuracy. 👉 #Biomarkers #Amyloid #Alzheimer #Diagnosis
0
2
4
Happy to share our new manuscript in @AlzheimersRes 🔬We show that synaptic biomarkers (NPTX2, SNAP25 and Ng) in CSF can be used to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders & #alzheimers 👉
0
0
3
📢 We are looking for an Administrative Logistics Coordinator to join us! Are you: 📦Experienced in logistic & administrative processes 💻Able to work independently & accurately 💡An organizational talent with good communicational skills (EN & NL) 👉
0
0
0
📢 We are looking for a scientist to expand our in-house service testing and reagent business activity! This includes production of immunoassay reagents, process and product quality control steps and analytical validation of the assays. 👉 Apply now:
0
0
0